Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
Other
100798-HMO-CTIL
NCT00148993
2.
A Phase I/Ii Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells After High-Dose Chemotherapy And Autologous Stem Cell Rescue In Patients With High Risk Neuroblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Biomarker/Laboratory analysis, Treatment
Active
Under 21
Other
22053
NCT00703222
3.
Allogeneic Whole Cell Cancer Vaccine for Metastatic Epithelial Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Approved-not yet active
18 and over
Other
0359-08-HMO-CTIL
NCT00722228
Last Modified:
5/22/2008
 
First Published:
1/18/2008
4.
Phase II Study of Vaccine Therapy Comprising Allogeneic Tumor Cells and GM.CD40L in Combination With Tretinoin and Cyclophosphamide in Patients Who Have Completed First-Line Chemotherapy for Metastatic Adenocarcinoma of the Lung
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
MCC-14744
MCC 14744, MCC-104490, MCC-0534-NE, NIH-OBA-0608-801, NCT00601796
5.
Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
CTN-0505
UKIRB 06-0716-F3R, ULIRB 065.07, CIRB 1079747, NCT00654030
First Published:
4/8/2008
6.
Phase I Study of Adjuvant Cyclophosphamide and Adjuvant Vaccine Therapy Comprising Allogeneic Colon Cancer Cells and K562/GM-CSF Cells in Patients With Resected Hepatic Metastases Secondary to Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
JHOC-J0745
J0745, JHOC-NA_00009345, NCT00656123
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute